B7-H3-positive Relapsed/ Refractory Neuroblastoma
1 clinical trials · Condition
◉ Watch B7-H3-positive Relapsed/ Refractory Neuroblastoma
| Record | Firm | Date |
|---|---|---|
| TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma (NCT05562024) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2022-12-30 |
Track B7-H3-positive Relapsed/ Refractory Neuroblastoma automatically
Every clearance here is in the API, with alerts when new ones post.